Ozempic in the news

Ozempic is growing in popularity -- it's also sending people to the ER

Read on: Independent

Ozempic is growing in popularity -- it's also sending people to the ER

Read on: Independent

Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic

Read on: CNBC News

Ozempic maker spending more than $3m to lobby fat cats in Washington as weight-loss drugs faces regulatory decisions

Read on: Independent

Lilly Soars After Pill Shows Its as Good as Ozempic.com

Read on: Bloomberg

Pfizer just had a big setback in its race for an Ozempic competitor

Read on: Quartz

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

Read on: Quartz

Viking Therapeutics closer to bringing its Ozempic competitor to market

Read on: Quartz

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Read on: Quartz

Woman on Ozempic switched to chia seeds, this was the result

Read on: Times of India

Hims & Hers can't sell off-brand Ozempic forever. But it can still sell these weight loss drugs

Read on: Quartz

Healthy Returns: Ozempic helps curb alcohol use in new study -- and doctors are concerned about telehealth GLP-1s

Read on: CNBC News

Ozempic and Wegovy officially moved off FDA's drug shortage list

Read on: The Hill

Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy

Read on: The New York Times

Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup

Read on: Quartz

Ozempic has curbed the obesity crisis. Has it killed the joy of food?

Read on: Financial Times

The weight-loss drugs being tested in 2025: will they beat Ozempic?

Read on: Nature

Trump's Medicaid freeze, Ozempic for kidney disease, and 23andMe for sale: Pharma news roundup

Read on: Quartz

An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs

Read on: Gizmodo